{
    "title": "Roche breast cancer drug shows \"unprecedented\" survival benefit",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2772421/Roche-breast-cancer-drug-shows-unprecedented-survival-benefit.html",
    "date": "2014-09-28",
    "keywords": [
        "breast",
        "cancer",
        "perjeta",
        "drug",
        "herceptin",
        "roche",
        "her2",
        "survival",
        "gmt",
        "september",
        "chemotherapy",
        "researcher",
        "oncology",
        "study",
        "disease",
        "time",
        "protein",
        "combination",
        "benefit",
        "email",
        "ben",
        "hirschlermadrid",
        "trial",
        "boosting",
        "use",
        "form",
        "type",
        "quarter",
        "top",
        "medicine",
        "alonethe",
        "improvement",
        "lead",
        "swain",
        "washington",
        "hospital",
        "center",
        "society",
        "congress",
        "sundayperjeta",
        "period",
        "data",
        "resultsjavier",
        "vall",
        "institute",
        "barcelona",
        "standard",
        "care",
        "patientsa",
        "reaction",
        "oncologist",
        "year",
        "consensus",
        "thomson",
        "challenge",
        "healthcare",
        "product",
        "position",
        "success",
        "company",
        "world",
        "inclusion",
        "prescribing",
        "information",
        "perjetaboth",
        "function",
        "gene",
        "pertuzumab",
        "part",
        "safety",
        "profile",
        "analysis",
        "madrid",
        "evidence",
        "safetythe",
        "drugmaker",
        "kadcyla",
        "weekend",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}